Search research articles
Contact Us
Filters
Showing results (241-250 of 268) with videos related to
Page
of 27
Sort By:
Gastroenterology
|
July 2, 2013
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection
Patrick Marcellin, Curtis Cooper, Luis Balart, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
BMJ Open
|
August 22, 2023
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
Felice Cinque, Sahar Saeed, Dana Kablawi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
International Journal of Epidemiology
|
February 21, 2012
Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS)
Sean B Rourke, Sandra Gardner, Ann N Burchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
Jordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
June 17, 2017
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada
Anita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 268) with videos related to
Sort By:
Page
of 27
Gastroenterology
|
July 2, 2013
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection
Patrick Marcellin, Curtis Cooper, Luis Balart, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
BMJ Open
|
August 22, 2023
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
Felice Cinque, Sahar Saeed, Dana Kablawi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
International Journal of Epidemiology
|
February 21, 2012
Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS)
Sean B Rourke, Sandra Gardner, Ann N Burchell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study
Jordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
June 17, 2017
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada
Anita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Page
of 27